V-set domain containing T-cell activation inhibitor-1 (VTCN1): A potential target for the treatment of autoimmune diseases

J Vaishnav, F Khan, M Yadav, N Parmar, H Buch… - Immunobiology, 2022 - Elsevier
Autoimmunity eventuates when the immune system attacks self-molecules as a result of the
breakdown in immune tolerance. Targeting autoimmune diseases via immunomodulation …
被引用次数：12 相关文章

V-set domain containing T-cell activation inhibitor-1 (VTCN1): A potential target for the treatment of autoimmune diseases.

J Vaishnav, F Khan, M Yadav, N Parmar, H Buch… - …, 2022 - europepmc.org
Autoimmunity eventuates when the immune system attacks self-molecules as a result of the
breakdown in immune tolerance. Targeting autoimmune diseases via immunomodulation …

V-set domain containing T-cell activation inhibitor-1 (VTCN1): A potential target for the treatment of autoimmune diseases

J Vaishnav, F Khan, M Yadav, N Parmar… - …, 2022 - pubmed.ncbi.nlm.nih.gov
Autoimmunity eventuates when the immune system attacks self-molecules as a result of the
breakdown in immune tolerance. Targeting autoimmune diseases via immunomodulation …